annb0t
Top 20
Key Insights
Using the 2 Stage Free Cash Flow to Equity, Fisher & Paykel Healthcare fair value estimate is NZ$18.66 Current share price of NZ$23.98 suggests Fisher & Paykel Healthcare is potentially 29% overvalued Analyst price target for FPH is NZ$24.53, which is 31% above our fair value estimate
Does the May share price for Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by taking the forecast futur...
>>> Read more: Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 29% Above Their Intrinsic Value Estimate
Using the 2 Stage Free Cash Flow to Equity, Fisher & Paykel Healthcare fair value estimate is NZ$18.66 Current share price of NZ$23.98 suggests Fisher & Paykel Healthcare is potentially 29% overvalued Analyst price target for FPH is NZ$24.53, which is 31% above our fair value estimate
Does the May share price for Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by taking the forecast futur...
>>> Read more: Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 29% Above Their Intrinsic Value Estimate
